Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Consulting agrmnt
Inv. presentation

Eloxx Pharmaceuticals, Inc. (ELOX) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2023 4 Rubin Steven D (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 2,859 options to buy @ $4, valued at $11.4k
01/31/2023 4 Kariv Tomer (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 2,859 options to buy @ $4, valued at $11.4k
01/31/2023 4 Androski Lindsay (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 2,859 options to buy @ $4, valued at $11.4k
01/27/2023 4 Aggarwal Sumit (PRESIDENT AND CEO) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 68,700 options to buy @ $4.27, valued at $293.3k
01/27/2023 4 MODUR VIJAY (HEAD OF R&D) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 30,000 options to buy @ $4.27, valued at $128.1k
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/17/2022 4 Walts Alan Edmund (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $0.26, valued at $5.2k
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Seehra Jasbir (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $0.26, valued at $5.2k
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 PAREKH RAJESH B (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $0.26, valued at $5.2k
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Kariv Tomer (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $0.26, valued at $5.2k
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/03/2021 4 Walts Alan Edmund (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Exercised 37,695 restricted stock units @ $0
12/03/2021 4 Aggarwal Sumit (PRESIDENT AND CEO) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 81,933 shares @ $0.72, valued at $59k
Exercised 279,158 restricted stock units @ $0
12/03/2021 4 MODUR VIJAY (HEAD OF R&D) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 64,373 shares @ $0.72, valued at $46.3k
Exercised 219,326 restricted stock units @ $0
12/01/2021 4 Geffken Daniel E. (INTERIM CFO) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Bought 50,000 shares @ $0.72, valued at $36k
07/30/2021 4 Belloff Neil S. (COO, GENERAL COUNSEL &CORP SEC) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 459 shares @ $1.32, valued at $605.9
Exercised 1,563 restricted stock units @ $0
05/26/2021 4 Belloff Neil S. (COO, GENERAL COUNSEL &CORP SEC) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 1,835 shares @ $1.39, valued at $2.6k
Exercised 6,250 restricted stock units @ $0
05/20/2021 4 Walts Alan Edmund (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 3,334 options to buy @ $1.48, valued at $4.9k
05/20/2021 4 PAREKH RAJESH B (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 3,334 options to buy @ $1.48, valued at $4.9k
05/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2021 4 Nussbaum Ran (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $1.48, valued at $29.6k
05/20/2021 4 Kariv Tomer (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $1.48, valued at $29.6k
05/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2021 4 Rubin Steven D (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $1.48, valued at $29.6k
05/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 MODUR VIJAY (HEAD OF R&D) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 496,204 options to buy @ $1.41, valued at $699.6k
05/18/2021 4 Aggarwal Sumit (PRESIDENT AND CEO) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 992,409 options to buy @ $1.41, valued at $1.4M
05/17/2021 4 PAREKH RAJESH B (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Bought 84,776 shares @ $1.35, valued at $114.4k
Bought 2,381,890 shares @ $1.35, valued at $3.2M
05/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy